Last reviewed · How we verify

Therapeutic plasma exchange — Competitive Intelligence Brief

Therapeutic plasma exchange (Therapeutic plasma exchange) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Apheresis procedure / Extracorporeal therapy. Area: Immunology / Neurology / Hematology.

phase 3 Apheresis procedure / Extracorporeal therapy Immunology / Neurology / Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Therapeutic plasma exchange (Therapeutic plasma exchange) — Centre Hospitalier St Anne. Therapeutic plasma exchange removes pathogenic antibodies, immune complexes, and other harmful plasma constituents by separating and replacing the patient's plasma with donor plasma or albumin solution.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Therapeutic plasma exchange TARGET Therapeutic plasma exchange Centre Hospitalier St Anne phase 3 Apheresis procedure / Extracorporeal therapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Apheresis procedure / Extracorporeal therapy class)

  1. Centre Hospitalier St Anne · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Therapeutic plasma exchange — Competitive Intelligence Brief. https://druglandscape.com/ci/therapeutic-plasma-exchange. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: